Berlin Registry of Right Heart Interventions

Tricuspid Regurgitation Clinical Trial

Official title: Berlin Registry of Right Heart Interventions

Status Recruiting

Clinical Trial Summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

Clinical Trial Description

The subject of the study is to register interventional therapies of right heart diseases (such as "cardioband" and "edge-to-edge" techniques of the tricuspid valve) performed in Berlin/ Brandenburg (primarily at the Charité, Universitätsmedizin Berlin). Based on the development and the increasing use of interventional therapies in tricuspid and pulmonary valve diseases, the impact on the patients' symptoms and life expectancy after interventions will be investigated. The aim is to identify patient subgroups that benefit the most.

Primary endpoints: Total mortality, cardiovascular mortality, heart failure hospitalization.

Secondary endpoints: NYHA class, NTproBNP, liver and kidney function (laboratory measurements), valve function, cardiac function, and cardiac morphology. ;

Related Conditions & MeSH terms

• Pulmonary Regurgitation
• Pulmonary Valve Insufficiency
• Tricuspid Regurgitation
• Tricuspid Valve Insufficiency

• NCT number: NCT04570163
• Study type: Observational [Patient Registry]
• Source: Charite University, Berlin, Germany
• Contact: Henryk Dreger, Prof. Dr. med.
• Phone: +4930450613496
• Email: henryk.dreger@charite.de
• Status: Recruiting
• Start date: June 16, 2020
• Completion date: December 31, 2025